Search results for "hepatology"

showing 10 items of 2737 documents

The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma

2021

Incidence and mortality of intrahepatic cholangiocarcinoma (iCCA) have been increasing continuously. Recent studies suggest that the combination of palliative chemotherapy (pCTX) and transarterial chemoembolization (TACE) improves overall survival (OS). This study aimed to evaluate the outcome of patients treated with TACE and pCTX in unresectable iCCA at our tertiary care center. A group of 14 patients was treated with both pCTX and TACE. The non-randomized control group of 59 patients received pCTX alone. Patients received a median of two pCTX lines in both groups. Those treated with TACE underwent a median number of 3.5 sessions. Median OS from the time of unresectability was 26.2 months…

medicine.medical_specialtycombined modality therapymedicine.medical_treatmentchemotherapyGastroenterologysurvivalArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineCombined Modality TherapyStage (cooking)chemoembolizationIntrahepatic CholangiocarcinomaChemotherapyPerformance statusbusiness.industryIncidence (epidemiology)RGeneral MedicinePalliative chemotherapy030220 oncology & carcinogenesisPropensity score matchingMedicine030211 gastroenterology & hepatologybusinesscholangiocarcinomaJournal of Clinical Medicine
researchProduct

Case report of a large cephalic vein aneurysm inducing heart failure in a renal transplant patient with radio-cephalic fistula for haemodialysis

2020

Highlights • The venous aneurysm is one of the most common complications of autologous AVF. • The vein aneurysm should be treat by surgical resection and anastomotic ligature. • AVF shouldn’t be ligated from 1-year kidney transplantation except in some cases. • Surgical ligation to prevent complications could be considered an option.

medicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesFistulaArteriovenous fistulaCase ReportHeart failure03 medical and health sciences0302 clinical medicineAneurysmmedicinecardiovascular diseasesVeinKidney transplantationArteriovenous fistulaCephalic veinbusiness.industryRenal transplantationmedicine.diseaseSurgeryTransplantationmedicine.anatomical_structure030220 oncology & carcinogenesiscardiovascular system030211 gastroenterology & hepatologySurgerybusinessKidney diseaseSurgical repairInternational Journal of Surgery Case Reports
researchProduct

Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus

2021

Summary There are no internationally recognized criteria available to determine preparedness for hospital discharge after esophagectomy. This study aims to achieve international consensus using Delphi methodology. The expert panel consisted of 40 esophageal surgeons spanning 16 countries and 4 continents. During a 3-round, web-based Delphi process, experts voted for discharge criteria using 5-point Likert scales. Data were analyzed using descriptive statistics. Consensus was reached if agreement was ≥75% in round 3. Consensus was achieved for the following basic criteria: nutritional requirements are met by oral intake of at least liquids with optional supplementary nutrition via jejunal fe…

medicine.medical_specialtydischarge criteriaConsensusDelphi Techniquemedicine.medical_treatmentDelphi methodVital signs03 medical and health sciencesTumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]0302 clinical medicineAll institutes and research themes of the Radboud University Medical CenterSurveys and QuestionnairesmedicineHumansFeeding tubecomputer.programming_languageHospital stayDescriptive statisticsddc:617business.industryGastroenterologyGeneral Medicinemedicine.diseaseColorectal surgeryDischarge criteriahospital stayPatient Discharge3. Good healthEsophagectomyDelphi consensusEsophagectomy030220 oncology & carcinogenesis030211 gastroenterology & hepatologyMedical emergencyOutcomes researchbusinesscomputerDelphi
researchProduct

Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels

2008

Abstract A persistent increase in non-virus non-alcohol related aminostransferase levels can have multiple causes, which differ in terms of prevalence and clinical importance. In the general population, the most frequent cause is non-alcoholic hepatic steatosis, which can evolve into steato-hepatitis and cirrhosis. The treatment for steatosis and non-alcoholic steato-hepatitis consists of modifying lifestyles, whereas the effectiveness of drug treatment remains to be determined. Other much less frequent (yet not rare) causes of persistent non-virus non-alcohol related elevations in aminotransferase levels are celiac disease and hemochromatosis, whereas autoimmune hepatitis, primary biliary …

medicine.medical_specialtyeducation.field_of_studyCirrhosisHepatologybusiness.industryPopulationGastroenterologyAutoimmune hepatitisDiseasemedicine.diseaseAsymptomaticPrimary sclerosing cholangitisPrimary biliary cirrhosisInternal medicineImmunologyEpidemiologyMedicinemedicine.symptombusinesseducationDigestive and Liver Disease
researchProduct

2019

Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in a prospectively enrolling real-life study cohort to inform physicians on the cardiovascular (CV) event risk based on these changes. A total of 304 patients with histologically confirmed NAFLD were included (mean age, 52 years; equal sex distribution). Of these, 129 (42.4%) patients exhibited a NAFLD activity score ≥4 and 186 (61.2%) had at least intermediate fibrosis ≥F2. The median TC levels were 2…

medicine.medical_specialtyeducation.field_of_studyFramingham Risk ScoreHepatologybusiness.industryPopulationmedicine.diseaseGastroenterologyFibrosisInterquartile rangeInternal medicineCohortNonalcoholic fatty liver diseasemedicinelipids (amino acids peptides and proteins)In patienteducationbusinessCause of deathHepatology Communications
researchProduct

Survival of patients with gastric lymphoma in Germany and in the United States

2015

Background and Aim This study aims to examine survival for gastric lymphomas and its main subtypes, mucosa-associated lymphoid tissue lymphoma (MALT), and diffuse large B-cell lymphoma (DLBCL), in Germany and in the United States. Methods Data for patients diagnosed in 1997–2010 were used from 10 population-based German cancer registries and compared to the data from the US Surveillance, Epidemiology and End Results (SEER) 13 registries database. Patients age 15–74 diagnosed with gastric lymphomas were included in the analysis. Period analysis and modeled period analysis were used to estimate 5-year and 10-year relative survival (RS) in 2002–2010 and survival trends from 2002–2004 to 2008–2…

medicine.medical_specialtyeducation.field_of_studyHepatologyRelative survivalbusiness.industryGastric lymphomaPopulationGastroenterologymedicine.diseaseGastroenterologySurgeryCancer registryLymphomaimmune system diseaseshemic and lymphatic diseasesInternal medicineMedicinebusinesseducationMucosa-associated lymphoid tissueDiffuse large B-cell lymphomaSurvival rateJournal of Gastroenterology and Hepatology
researchProduct

PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes

2011

Context: Recently, it has been shown that an allele in the adiponutrin (PNPLA3) gene was strongly associated with increased liver fat content (LFC) and liver fibrosis independent of visceral adiposity and insulin resistance. Objective: In this study, we set out to determine whether the PNPLA3 rs738409 polymorphism was associated with liver fibrosis in unselected patients with type 2 diabetes. Design, setting and participants: Two hundred and thirty-four patients with type 2 diabetes were included in this study. Main outcome measures: LFC was evaluated using 1H-MR spectroscopy; fibrosis was measured using the non-invasive FibroTest®. Results: Advanced liver fibrosis (stage F2 or above) was o…

medicine.medical_specialtyeducation.field_of_studyHepatologybusiness.industryFibroTestType 2 diabetesmedicine.diseaseGastroenterologyEndocrinologyInsulin resistanceFibrosisPolymorphism (computer science)Internal medicinemedicineAdiponutrinSteatosisbusinesseducationBody mass indexLiver International
researchProduct

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve …

2011

Summary.  In chronic hepatitis C (CHC), treatment duration may be individualized according to time to first undetectable hepatitis C virus (HCV) RNA, with patients who attain undetectable HCV RNA early in treatment being candidates for shorter regimens. The aim of this study was to determine the relapse rate in patients with CHC genotype (G) 1 infection and low baseline viral load who achieved undetectable HCV RNA by week 4 [rapid virologic response (RVR)] when treated for 24 weeks. This was an open-label, multicentre, noninterventional study. Adult patients with G1 CHC infection and baseline viral load <600,000 IU/mL who attained RVR were treated with peginterferon alfa-2b (1.5 μg/kg/week)…

medicine.medical_specialtyeducation.field_of_studyHepatologybusiness.industryRibavirinHepatitis C virusPopulationvirus diseasesmedicine.disease_causeGastroenterologychemistry.chemical_compoundInfectious DiseaseschemistryVirologyInternal medicineImmunologymedicineClinical endpointPeginterferon alfa-2bRapid Virologic ResponseeducationbusinessAdverse effectViral loadmedicine.drugJournal of Viral Hepatitis
researchProduct

Recognition and characterization of small colonic neoplasia with high-definition colonoscopy using i-Scan is as precise as chromoendoscopy

2010

Abstract Background The EPKi system (Pentax, Japan) enables resolution above HDTV. Aim of the study was to test the efficacy of HD+ alone and with the new post-processing digital filter i-Scan or chromoendoscopy (Methylene blue 0.1%) in screening for colorectal cancer. We focused on lesions less than 5 mm as a surrogate marker for the optical possibilities of the EPKi system. Methods The last 30 cm of the colon in a screening population were inspected with HD+ alone, in combination with i-Scan (2:1 randomisation) and subsequently with chromoendoscopy. All lesions were characterized and targeted biopsies were performed. Results i-Scan augmented in 69 patients the identification of lesions fr…

medicine.medical_specialtyeducation.field_of_studyHepatologymedicine.diagnostic_testColorectal cancerSurrogate endpointbusiness.industryHigh definition endoscopyPopulationGastroenterologyColonoscopymedicine.diseaseTime efficientChromoendoscopymedicineHigh definitionRadiologyeducationbusinessDigestive and Liver Disease
researchProduct

Imaging Approach for Evaluation of Focal Liver Lesions

2009

Focal liver lesions are common in the general population. Radiology (imaging) plays a pivotal role for the diagnosis, staging, treatment planning, and follow-up of focal liver lesions. To maximize lesion detection and characterization, imaging needs to be performed with appropriate equipment by using protocols carefully designed on the basis of the underlying clinical context. In addition, the decision of an imaging modality cannot be based on the diagnostic accuracy of an imaging test solely but must also consider patient safety and cost-effectiveness.

medicine.medical_specialtyeducation.field_of_studyModality (human–computer interaction)Hepatologymedicine.diagnostic_testbusiness.industryLiver DiseasesRadiographyPopulationGastroenterologyContext (language use)Magnetic resonance imagingRadiographyPatient safetyLiverPositron emission tomographymedicineHumansRadiologybusinessNuclear medicineRadiation treatment planningeducationUltrasonographyClinical Gastroenterology and Hepatology
researchProduct